TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Aspiria AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
20,278
|
20,237
|
15,913 |
Financial expenses |
2
|
1
|
0 |
Earnings before taxes |
51
|
2,111
|
1,091 |
Total assets |
6,925
|
9,582
|
7,501 |
Current assets |
6,870
|
9,476
|
7,190 |
Current liabilities |
4,188
|
6,694
|
4,963 |
Equity capital |
2,736
|
2,887
|
2,537 |
- share capital |
564
|
604
|
586 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
39.5%
|
30.1%
|
33.8% |
Turnover per employee | |||
Profit as a percentage of turnover |
0.3%
|
10.4%
|
6.9% |
Return on assets (ROA) |
0.8%
|
22.0%
|
14.5% |
Current ratio |
164.0%
|
141.6%
|
144.9% |
Return on equity (ROE) |
1.9%
|
73.1%
|
43.0% |
Change turnover |
1,382
|
3,830
|
-6,889 |
Change turnover % |
7%
|
23%
|
-30% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.